{
    "clinical_study": {
        "@rank": "154551", 
        "acronym": "ParaEpi", 
        "arm_group": [
            {
                "arm_group_label": "Epidural Catheter 0.2% ropivacaine", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive an infusion of 0.2% ropivacaine at a range of 0-10 mL/hr through an epidural catheter.  They will also receive an infusion of saline  at a rate of 0-10 mL/hr through a paravertebral catheter."
            }, 
            {
                "arm_group_label": "Paravertebral Catheter 0.4% ropivacaine", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive an infusion of 0.4% ropivacaine at a range of 0-10mL/hr through a paravertebral catheter.  They will also receive an infusion of saline at a range of 0-10mL/hr through an epidural catheter."
            }
        ], 
        "brief_summary": {
            "textblock": "Paravertebral analgesia is non-inferior to epidural analgesia for pain control and superior\n      to epidural analgesia in terms of the main complication of hypotension."
        }, 
        "brief_title": "Pilot Study: Paravertebral Analgesia vs Epidural Analgesia After Thoracotomy", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypotension", 
        "condition_browse": {
            "mesh_term": "Hypotension"
        }, 
        "detailed_description": {
            "textblock": "There is some evidence that paravertebral analgesia is similar to epidural analgesia in\n      efficacy but superior in maintenance of blood pressure. This is a double blind, randomized\n      control trial comparing paravertebral catheters to epidural catheters for the management of\n      post thoracotomy analgesia.  Both groups will undergo placement of a pre-induction epidural\n      catheter as well as a surgically placed paravertebral catheter.  Patients will also receive\n      PCA morphine.  The primary outcome will be daily morphine use measured in milligrams.  The\n      co-primary outcome will be time spent with a systolic blood pressure below 90mmHg.  Outcomes\n      will be measured during the first five postoperative days."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Open thoracotomy\n\n          -  Age > 18 yo\n\n          -  Able to use a patient controlled analgesia device\n\n        Exclusion Criteria:\n\n          -  Previous thoracotomy\n\n          -  Previous spine surgery\n\n          -  Chronic pain condition\n\n          -  Ongoing narcotic use\n\n          -  Prior narcotic abuse\n\n          -  Active chest infection\n\n          -  Chest trauma\n\n          -  Anticoagulation\n\n          -  Other contraindication to epidural catheter placement\n\n          -  Allergy to local anesthetic or narcotic"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01700491", 
            "org_study_id": "B2012:038"
        }, 
        "intervention": [
            {
                "arm_group_label": "Epidural Catheter 0.2% ropivacaine", 
                "description": "0.2% ropivacaine into epidural space and saline into paravertebral space", 
                "intervention_name": "Epidural Catheter 0.2% ropivacaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Paravertebral Catheter 0.4% ropivacaine", 
                "description": "0.4% ropivacaine into paravertebral space and saline into the epidural space", 
                "intervention_name": "Paravertebral Catheter 0.4% ropivacaine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Paravertebral Catheter", 
            "Epidural Catheter", 
            "Analgesia", 
            "Hypotension", 
            "Analgesia,Epidural", 
            "Analgesia,Paravertebral"
        ], 
        "lastchanged_date": "February 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba", 
                        "zip": "R3A 1R9"
                    }, 
                    "name": "Health Sciences Centre"
                }, 
                "investigator": [
                    {
                        "last_name": "Ryan Pauls, MD FRCS(C)", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Rob Brown, MD FRCP(C)", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Purnima Rao, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sadeesh Srinathan, MD, FRCS", 
                    "phone": "2047873791"
                }, 
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba", 
                        "zip": "R3A1R9"
                    }, 
                    "name": "Health Sciences Centre"
                }, 
                "investigator": {
                    "last_name": "Sadeesh Srinathan, MD, FRCS", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pilot Study: A Non-Inferiority Trial of the Analgesic Effect of Paravertebral Analgesia to Epidural Analgesia for the Management of Post-Operative Pain After Thoracotomy", 
        "overall_contact": {
            "email": "ssrinathan@gmail.com", 
            "last_name": "Sadeesh Srinathan, Medicine", 
            "phone": "(204) 787-7143"
        }, 
        "overall_contact_backup": {
            "email": "umrao@cc.umanitoba.ca", 
            "last_name": "Purnima Rao, Medicine", 
            "phone": "(204) 688-6309"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Manitoba", 
                "last_name": "Sadeesh Srinathan, MD, FRCS C-Th, FRCS(C)", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Manitoba", 
                "last_name": "Stephen Kowalski, MD, FRCP", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Manitoba", 
                "last_name": "Rob Brown, MD, FRCP", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Manitoba", 
                "last_name": "Purnima Rao, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Total cumulative dose of morphine equivalent narcotics.", 
            "measure": "Analgesic Effect", 
            "safety_issue": "No", 
            "time_frame": "At postoperative day 5"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01700491"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Manitoba", 
            "investigator_full_name": "Sadeesh Srinathan, MD", 
            "investigator_title": "Assistant Professor- Department of Thoracic Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Cumulative time in which the systolic blood pressure is below 90mmHg.", 
            "measure": "Hypotension", 
            "safety_issue": "Yes", 
            "time_frame": "At postoperative day 5"
        }, 
        "source": "University of Manitoba", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Department of Anesthesia and Perioperative Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Department of Surgery", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Manitoba", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}